An announcement from Anika Therapeutics (ANIK) is now available.
Anika Therapeutics, Inc. has struck a Cooperation Agreement with Caligan Partners LP and affiliates, leading to the expansion of its Board of Directors to ten members, the appointment of Jellison and Capper as directors, and the launch of a $40 million share repurchase program. As part of the agreement, the board will be reduced back to nine members post the 2024 Annual Meeting, and the Investor Group has committed to voting with the board’s recommendations until just before the 2025 annual meeting. This arrangement also includes provisions for quarterly meetings with the Capital Allocation Committee and management, as well as standstill and non-disparagement clauses.
Learn more about ANIK stock on TipRanks’ Stock Analysis page.
